BioHarvest Sciences (NASDAQ:BHST – Get Free Report) and Honest (NASDAQ:HNST – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.
Insider & Institutional Ownership
45.5% of Honest shares are owned by institutional investors. 9.4% of Honest shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares BioHarvest Sciences and Honest”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BioHarvest Sciences | $34.51 million | 1.03 | -$11.14 million | ($0.52) | -3.50 |
| Honest | $371.32 million | 1.76 | -$15.69 million | ($0.11) | -54.09 |
BioHarvest Sciences has higher earnings, but lower revenue than Honest. Honest is trading at a lower price-to-earnings ratio than BioHarvest Sciences, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and price targets for BioHarvest Sciences and Honest, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BioHarvest Sciences | 1 | 0 | 2 | 0 | 2.33 |
| Honest | 2 | 4 | 2 | 1 | 2.22 |
BioHarvest Sciences currently has a consensus price target of $6.50, indicating a potential upside of 257.14%. Honest has a consensus price target of $4.84, indicating a potential downside of 18.66%. Given BioHarvest Sciences’ stronger consensus rating and higher possible upside, research analysts clearly believe BioHarvest Sciences is more favorable than Honest.
Profitability
This table compares BioHarvest Sciences and Honest’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BioHarvest Sciences | -31.21% | -58.30% | -25.60% |
| Honest | -3.56% | 4.31% | 3.33% |
Risk & Volatility
BioHarvest Sciences has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Honest has a beta of 2.24, indicating that its stock price is 124% more volatile than the S&P 500.
Summary
Honest beats BioHarvest Sciences on 10 of the 14 factors compared between the two stocks.
About BioHarvest Sciences
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
About Honest
The Honest Company, Inc. manufactures and sells diapers and wipes, skin and personal care, and household and wellness products. The company also offers baby clothing and nursery bedding products. It sells its products through digital and retail sales channels, such as its website and third-party ecommerce sites, as well as brick and mortar retailers. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
